A phase II study of tinostamustine in patients (pts) with advanced solid tumours

被引：0
|
作者：
Tinker, Anna
Strauss, James Fredric
Schneider, Reva
Chugh, Rashmi
Curigliano, Giuseppe
Di Nicola, Massimo A.
Oaknin, Ana
Janik, Tomas
Hilgier, Kasia
Manamley, Nick
Kummar, Shivaani
机构：
[1] BC Canc Vancouver, Vancouver, BC, Canada
[2] Mary Crowley Canc Res, Dallas, TX USA
[3] Univ Michigan, Ann Arbor, MI USA
[4] Univ Milan, European Inst Oncol, IRCCS, Milan, Italy
[5] Fdn IRCCS Ist Nazl, Milan, Italy
[6] Hosp Univ Vall dHebron, Gynaecol Canc Programme, Vall dHebron Inst Oncol VHIO, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
[7] Mundipharma Res Ltd, Cambridge, England
[8] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3021
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II study of pemetrexed in patients (pts) with advanced neuroendocrine tumors (NETs)
    Bhargava, P.
    Earle, C. C.
    Zhu, A. X.
    Clark, J. W.
    Vincitore, M.
    Battu, S.
    Regan, E.
    Lawrence, C.
    Kulke, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] A phase I dose escalation study to assess the safety tolerability and pharmacokinetics of ETS2101 in patients (pts) with advanced solid tumours
    Plummer, R.
    Anthoney, A.
    Evans, J.
    Haris, N.
    D'Archangelo, M.
    Slater, S.
    Campbell, S.
    Brindley, C.
    Self, S.
    McKeown, P.
    Lavin, S.
    Hynes, D.
    Flores, M. V.
    Pedret-Dunn, A.
    Laffranchi, B.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S58 - S59
  • [23] Phase I study of afatinib combined with nintedanib in patients with advanced solid tumours
    Bahleda, Rastislav
    Hollebecque, Antoine
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Deutsch, Eric
    Amellal, Nadia
    Farace, Francoise
    Ould-Kaci, Mahmoud
    Roux, Flavien
    Marzin, Kristell
    Soria, Jean-Charles
    BRITISH JOURNAL OF CANCER, 2015, 113 (10) : 1413 - 1420
  • [24] Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours
    Cresta, S.
    Sessa, C.
    Catapano, C. V.
    Gallerani, E.
    Passalacqua, D.
    Rinaldi, A.
    Bertoni, F.
    Vigano, L.
    Maur, M.
    Capri, G.
    Maccioni, E.
    Tosi, D.
    Gianni, L.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (13) : 1829 - 1834
  • [25] Erratum: Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
    British Journal of Cancer, 1998, 77 (10) : 1714 - 1714
  • [26] Cabazitaxel in patients with advanced solid tumours: Results of a Phase I and pharmacokinetic study
    Dieras, V.
    Lortholary, A.
    Laurence, V.
    Delva, R.
    Girre, V.
    Livartowski, A.
    Assadourian, S.
    Semiond, D.
    Pierga, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (01) : 25 - 34
  • [27] Phase I study of afatinib combined with nintedanib in patients with advanced solid tumours
    Rastislav Bahleda
    Antoine Hollebecque
    Andrea Varga
    Anas Gazzah
    Christophe Massard
    Eric Deutsch
    Nadia Amellal
    Françoise Farace
    Mahmoud Ould-Kaci
    Flavien Roux
    Kristell Marzin
    Jean-Charles Soria
    British Journal of Cancer, 2015, 113 : 1413 - 1420
  • [28] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours
    Hollebecque, A.
    Bahleda, R.
    Faivre, L.
    Adam, J.
    Poinsignon, V.
    Paci, A.
    Gomez-Roca, C.
    Thery, J. C.
    Le Deley, M. C.
    Varga, A.
    Gazzah, A.
    Ileana, E.
    Gharib, M.
    Angevin, E.
    Malekzadeh, K.
    Massard, C.
    Soria, J. C.
    Spano, J. P.
    EUROPEAN JOURNAL OF CANCER, 2017, 81 : 81 - 89
  • [29] A phase I study of HYB2055 in patients (pts) with advanced solid malignancies
    Hwang, JJ
    Park, S
    Amin, A
    Martin, RR
    Sullivan, T
    Burns, T
    Agrawal, S
    Waxdal, MJ
    Malik, S
    Marshall, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 222S - 222S
  • [30] MEDIOLA: A phase I/II, open-label trial of olaparib in combination with durvalumab (MEDI4736) in patients (pts) with advanced solid tumours
    Domchek, S.
    Bang, Y-J
    Coukos, G.
    Kobayashi, K.
    Baker, N.
    McMurtry, E.
    Song, W.
    Kaufman, B.
    ANNALS OF ONCOLOGY, 2016, 27
12345